Commencez
Abbvie Inc.Abbvie Inc.Abbvie Inc.

Abbvie Inc.

Pas de trades
Voir sur les super-graphiques
Vue d'ensemble Finances Actualités Idées Discussions Données techniques Prévision Saisonniers
Obligations

Obligations de 4AB

Voici la liste des obligations d'entreprise de Abbvie Inc. . Les investisseurs optent souvent pour les obligations d'une société en raison de leur stabilité accrue en période de volatilité du marché. Étudiez les prix, les rendements et d'autres statistiques et trouvez un investissement fiable.
Symbole
YTM %
Volume
Prix %
Coupon %
Date d'échéance
Montant en suspens
Valeur nominale
Montant min de la dénomination
Émetteur
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
6,56%15 K79,63%4,85%2044-06-1565,232 M USD1 000,00 USD2 000,00 USDAllergan Funding SCS
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
6,54%84 K78,38%4,63%2042-10-0167,493 M USD1 000,00 USD2 000,00 USDActavis, Inc.
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
6,44%10 K79,20%4,75%2045-03-1553,51 M USD1 000,00 USD2 000,00 USDAllergan Funding SCS
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
5,75%64 K90,42%4,55%2035-03-15107,646 M USD1 000,00 USD2 000,00 USDAllergan Funding SCS
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5,70%50 K89,00%3,20%2029-11-2162,515 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5,51%11,827 M99,72%5,50%2064-03-151,5 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
4ABBABBVIE 15/45
5,42%090,56%4,70%2045-05-142,7 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
5,40%466 K90,66%4,63%2042-10-01389,217 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5,39%5 K100,15%5,40%2054-03-153 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
US287YAW9ABBVIE 16/46
5,38%087,30%4,45%2046-05-142 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
5,37%1,42 M93,28%4,85%2044-06-151,008 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
5,36%484 K99,81%5,35%2044-03-15750 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
5,35%508 K92,15%4,75%2045-03-15827,091 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
5,34%3,7 M93,14%4,88%2048-11-141,75 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
5,31%10,37 M88,93%4,40%2042-11-062,599 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
5,29%12 M84,40%4,25%2049-11-215,745 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
5,21%4,444 M87,50%4,05%2039-11-214 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
US287YAV1ABBVIE 16/36
5,14%092,56%4,30%2036-05-141 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
US287YAR0ABBVIE 15/35
5,09%095,11%4,50%2035-05-142,5 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
5,09%7,132 M95,60%4,55%2035-03-151,681 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
5,02%2,23 M100,21%5,05%2034-03-153 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
4,77%30 K92,98%3,20%2029-11-215,437 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
AA5QDALLERGAN FNDG 15/25
4,75%099,07%3,80%2025-03-15130,225 M USD1 000,00 USD2 000,00 USDAllergan Funding SCS
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
4,75%096,53%2,95%2026-11-219,245 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
4,71%930 K100,34%4,80%2029-03-152,5 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
4,63%2,659 M100,37%4,80%2027-03-152,25 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
4,63%48 K98,60%4,25%2028-11-141,75 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
4,58%67 K96,85%2,95%2026-11-213,991 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4,58%87 K102,05%4,95%2031-03-152 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
US287YAY5ABBVIE 16/26
4,57%098,02%3,20%2026-05-142 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
4ABCABBVIE 15/25
4,29%099,32%3,60%2025-05-143,75 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5083839AbbVie Inc. 3.8% 15-MAR-2025
4,20%9,073 M99,60%3,80%2025-03-152,889 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
XS190919331ALLERGAN FNDG 18/28
3,81%095,57%2,63%2028-11-1572,107 M EUR1 000,00 EUR100 000,00 EURAllergan Funding SCS
XXS162262122ALLERGAN FNDG 17/29
3,78%093,07%2,13%2029-06-0136,462 M EUR1 000,00 EUR100 000,00 EURAllergan Funding SCS
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
3,07%0121,31%4,25%2049-11-214,95 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
3,03%0126,76%4,75%2045-03-155 K USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
2,96%0128,71%4,85%2044-06-15100 K USD1 000,00 USD2 000,00 USDAbbVie, Inc.
4ABGABBVIE 19/31
2,92%089,39%1,25%2031-11-18650 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
XS212591491ABBVIE 20/29
2,79%097,16%2,13%2029-06-01506,088 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
XS212591483ABBVIE 20/28
2,76%099,50%2,63%2028-11-15427,793 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
XS152090781ABBVIE 16/28
2,70%097,82%2,13%2028-11-17750 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
ABBV5066461AbbVie Inc. 2.6% 21-NOV-2024
2,63%106 K99,97%2,60%2024-11-213,739 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
4ABEABBVIE 19/27
2,54%094,81%0,75%2027-11-18750 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2,02%0123,74%4,55%2035-03-151 K USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4997740AbbVie Inc. 3.8% 15-MAR-2025
1,63%0102,15%3,80%2025-03-151,268 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4911714AbbVie Inc. 2.6% 21-NOV-2024
−3,63%0106,34%2,60%2024-11-2110,86 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
———4,40%2042-11-061,1 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5067241AbbVie Inc. 3.8% 15-MAR-2025
———3,80%2025-03-15—1 000,00 USD2 000,00 USDAbbVie, Inc.